Moderna
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Moderna and other ETFs, options, and stocks.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.
MRNA Key Statistics
MRNA News
Jefferies hosted a fireside meeting with Moderna (MRNA) management, where the company noted that COVID vaccines are currently not mandated and therefore those o...
Despite becoming a household name during the pandemic, Moderna (MRNA) stock has mostly fallen over the past three years amid decelerating sales and clinical pit...
Moderna (MRNA) stock has fallen 71% over the last six months. While there’s still potential for near-term revenue tailwinds in the form of emerging infectious d...
Analyst ratings
52%
of 29 ratingsMore MRNA News
Berenberg has initiated coverage of BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA), citing their leadership positions in mRNA medicine. The investment firm s...
Berenberg analyst Harry Gillis initiated coverage of Moderna (MRNA) with a Hold rating and $42 price target. The firm says mRNA will revolutionize the treatment...
A class action lawsuit was filed against Metagenomi Inc. (MGX) by Levi & Korsinsky on September 26, 2024. The plaintiffs (shareholders) alleged that they bought...
Last week, some large European and U.S. vaccine maker stocks fell in reaction to Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human S...
Moderna’s (NASDAQ:MRNA) steep fall on Friday after President-elect Donald Trump selected vaccine critic Robert F. Kennedy Jr. to head the U.S. Department of Hea...
